Literature DB >> 29904256

Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.

C Demosthenous1,2, G Rizos1, E Vlachaki3, G Tzatzagou1, M Gavra1.   

Abstract

BACKGROUND: Hemosiderosis in the absence of blood transfusions has been encountered in conditions associated with ineffective erythropoiesis but not in sickle-cell disease (SCD). Description of the case: We report a case of a 34-year-old Caucasian male, with a history of SCD and beta thalassemia (Hb S/β+-thal) who presented with acute painful crises. Despite never having received regular blood transfusions in the past, the patient demonstrated elevated ferritin levels and transferrin saturation of 83 %. Further evaluation revealed diffuse hepatocellular dysfunction and cirrhosis.
CONCLUSION: To the best of our knowledge, this is the first patient with Hb S/β+-thal without a prior history of chronic blood transfusions or other predisposing factors for liver disease who developed hemosiderosis and cirrhosis. The pathomechanism, in this case, is thought to be related to increased duodenal iron uptake secondary to premature red cell precursor death. Further studies are required to characterize ineffective intramedullary erythropoiesis and iron metabolism better, and to improve the existing management guidelines of iron overload. The data reported herein suggest that patients with hemoglobinotpathies should be screened for iron overload regardless of transfusion history. HIPPOKRATIA 2017, 21(1): 43-45.

Entities:  

Keywords:  Hb S/beta thalassemia; Hb S/β+-thal; Sickle-cell disease; cirrhosis ; hemosiderosis; thalassemia

Year:  2017        PMID: 29904256      PMCID: PMC5997016     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  16 in total

Review 1.  Sickle cell hepatopathy.

Authors:  S Banerjee; C Owen; S Chopra
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

2.  Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

Authors:  Ellen B Fung; Paul Harmatz; Meredith Milet; Samir K Ballas; Laura De Castro; Ward Hagar; William Owen; Nancy Olivieri; Kim Smith-Whitley; Deepika Darbari; Winfred Wang; Elliott Vichinsky
Journal:  Am J Hematol       Date:  2007-04       Impact factor: 10.047

Review 3.  Transfusion therapy for sickle cell disease: a balancing act.

Authors:  Stella T Chou
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.

Authors:  S K Ballas
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

5.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

Authors:  Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

6.  Sickle cell disease and hemochromatosis.

Authors:  M E Conrad
Journal:  Am J Hematol       Date:  1991-10       Impact factor: 10.047

7.  Clinical, hematological, and molecular features in Sicilians with Hb S-beta-thalassemia.

Authors:  G Schiliro; P Samperi; R Testa; R B Gupta; L H Gu; T H Huisman
Journal:  Am J Hematol       Date:  1992-12       Impact factor: 10.047

8.  Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.

Authors:  Philip A Berry; Timothy J S Cross; Swee Lay Thein; Bernard C Portmann; Julia A Wendon; John B Karani; Michael A Heneghan; Adrian Bomford
Journal:  Clin Gastroenterol Hepatol       Date:  2007-09-27       Impact factor: 11.382

9.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

Review 10.  Acute and chronic hepatobiliary manifestations of sickle cell disease: A review.

Authors:  Rushikesh Shah; Cesar Taborda; Saurabh Chawla
Journal:  World J Gastrointest Pathophysiol       Date:  2017-08-15
View more
  1 in total

Review 1.  Sickle Hepatopathy.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2020-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.